Back to search

Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance

Data up to Jan 2025

Published2005
Citations537
References43

Total Citations Per Year

Abstract

References (43)

The Hallmarks of Cancer

2000 • 27,569 citations

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

2001 • 11,070 citations

The Protein Kinase Complement of the Human Genome

2002 • 7,708 citations

Cellular survival: a play in three Akts

1999 • 4,229 citations

Promotion of microtubule assembly in vitro by taxol

1979 • 3,521 citations

Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

2004 • 3,278 citations

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

2003 • 2,691 citations

Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN

1998 • 2,505 citations

Taxol stabilizes microtubules in mouse fibroblast cells.

1980 • 1,942 citations

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

2001 • 1,678 citations

Pten is essential for embryonic development and tumour suppression

1998 • 1,507 citations

The tor pathway: a target for cancer therapy

2004 • 1,308 citations

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

2004 • 1,226 citations

Unlocking the potential of the human genome with RNA interference

2004 • 1,066 citations

Protein Kinase SGK Mediates Survival Signals by Phosphorylating the Forkhead Transcription Factor FKHRL1 (FOXO3a)

2001 • 850 citations

High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice

1998 • 823 citations

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

1992 • 732 citations

Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers

2004 • 517 citations

Analysis of Events Associated With Cell Cycle Arrest at G2 Phase and Cell Death Induced by Cisplatin

1990 • 447 citations

Transforming growth factor β signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis

2003 • 433 citations

Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.

2002 • 431 citations

Reduced MAP Kinase Phosphatase-1 Degradation After p42/p44 MAPK -Dependent Phosphorylation

1999 • 414 citations

Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway

1999 • 349 citations

A Network of Immediate Early Gene Products Propagates Subtle Differences in Mitogen-Activated Protein Kinase Signal Amplitude and Duration

2003 • 324 citations

Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway

2002 • 313 citations

ErbB2 Potentiates Breast Tumor Proliferation through Modulation of p27Kip1-Cdk2 Complex Formation: Receptor Overexpression Does Not Determine Growth Dependency

2000 • 304 citations

Mechanism of Action of Antitumor Drug Etoposide: A Review

1988 • 291 citations

Forkhead transcription factors contribute to execution of the mitotic programme in mammals

2001 • 282 citations

Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations

2005 • 273 citations

Small-molecule cyclin-dependent kinase modulators

2003 • 235 citations

Cooperation of the ErbB2 receptor and transforming growth factor β in induction of migration and invasion in mammary epithelial cells

2004 • 224 citations

MEK Inhibition Enhances Paclitaxel-induced Tumor Apoptosis

2000 • 222 citations

Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1

2003 • 192 citations

Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic.

2002 • 183 citations

Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha.

2003 • 154 citations

Gathering STYX: phosphatase-like form predicts functions for unique protein-interaction domains

1998 • 135 citations

A Single Mutation Converts a Novel Phosphotyrosine Binding Domain into a Dual-specificity Phosphatase

1995 • 121 citations

Calcium/Calmodulin-dependent Protein Kinase II Regulation of c-FLIP Expression and Phosphorylation in Modulation of Fas-mediated Signaling in Malignant Glioma Cells

2003 • 88 citations

Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of taxol and mitogen-activated protein kinase kinase inhibition.

2002 • 78 citations

Human JIK, a Novel Member of the STE20 Kinase Family That Inhibits JNK and Is Negatively Regulated by Epidermal Growth Factor

1999 • 77 citations

Genetic analysis identifies putative tumor suppressor sites at 2q35–q36.1 and 2q36.3–q37.1 involved in cervical cancer progression

2003 • 69 citations

Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life.

1993 • 58 citations

Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?

2001 • 45 citations

Cited By (0)

Loading...
Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of… (2005) – Nature Cell Biology | Metascience Observatory Explorer